CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

Protecting Release Timelines through Better Microbiology Testing

By

Life Sciences Review | Wednesday, September 16, 2026

A microbiology result that arrives late can hold a release decision in place even when every other quality check is complete. The deeper buying problem is repeat work. Poor sample intake or avoidable report revisions can turn an apparently fast laboratory into a source of delay. Executives evaluating an outside testing partner should look past the test menu and ask how reliably work moves from receipt through reporting under routine production pressure.


Technical fit starts with the methods a laboratory can perform consistently, not the number of services on its website. Environmental monitoring and preservative effectiveness work place different demands on sampling, media selection, incubation controls and interpretation. The laboratory should be able to explain how it handles those differences without introducing unnecessary variation between runs. For buyers in regulated life sciences, the useful distinction is whether procedures produce records that can support internal quality review and external inspection without creating a second round of clarification.


“PDA’s microbiology work includes environmental monitoring using air samplers and contact plates, plus preservative effectiveness and antimicrobial effectiveness testing under USP 51 and PCPC challenge methods.”


Sample movement can be just as consequential as bench work. Environmental monitoring samples may spend time in transit before plating, while routine submissions can lose days through intake backlogs or incomplete handoffs. Buyers should examine how quickly samples enter the laboratory workflow and whether assigned due dates reflect real capacity. Reporting discipline matters too. Preliminary results should arrive when promised and final reports should not routinely require correction. A low revision burden reduces the administrative drag placed on quality staff after the analytical work is finished.


Accreditation provides a reference point, but its practical value depends on how the laboratory applies its quality system between audits. Staffing depth, controlled procedures, training records and workload management offer a clearer view of whether service levels can be sustained as volume changes. An accredited laboratory that accepts more work than its bench can absorb may still miss deadlines. Procurement teams should therefore connect certification status to current staffing capacity rather than treating the certificate itself as a complete proxy for performance.


The strongest selection process tests these factors against the buyer’s own workflow. A provider may have the correct microbiology methods yet still be a poor fit if pickup arrangements or reporting practices create friction for the client. Contract terms and price matter, but they should be considered along with revision frequency and the laboratory’s ability to keep promised dates. The better fit is the laboratory whose technical scope is supported by a service model that remains predictable once routine volume begins.


PDA merits consideration for buyers that need microbiology testing tied closely to dependable sample handling and reporting. Its microbiology work includes environmental monitoring using air samplers and contact plates, plus preservative effectiveness and antimicrobial effectiveness testing under USP 51 and PCPC challenge methods. PDA has also added microbiology technicians and expanded its courier service for established clients within its service radius, allowing collected samples to be brought into the laboratory and plated the same day. Its ISO 17025 recertification gives buyers a quality-system reference point. For teams comparing laboratories on execution rather than test menus alone, this combination is relevant.


Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review . All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/deep-dive/protecting-release-timelines-through-better-microbiology-testing-nwid-3729.html